查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1800179

血管移植市场：2025-2030 年预测

Vascular Graft Market - Forecasts fom 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

血管移植市场预计将从 2025 年的 15.79 亿美元成长到 2030 年的 20.38 亿美元，复合年增长率为 5.23%。

全球血管移植市场正在经历显着增长，这主要归因于慢性肾臟病(CKD) 盛行率的上升以及心臟病等心血管疾病发病率的上升。这些疾病需要透析和冠状动脉绕道手术手术 (CABG) 等先进的外科手术干预，而这些手术严重依赖血管移植来恢復或维持重要的血流。随着这些疾病在全球范围内的负担加重，对可靠有效的血管移植的需求将持续增长，从而有望推动市场持续成长。

主要成长要素

心臟病发作的发生率增加

心臟病和中风的盛行率不断上升是推动血管移植市场发展的主要因素。冠状动脉疾病和使用微血管瓣重组等疾病需要进行冠状动脉绕道手术（CABG）等手术，而CABG是全球最常见的心血管手术之一。这些手术需求的不断增长推动了对血管移植的需求，而血管移植对于绕过阻塞的动脉并恢復血流至关重要。中风发生率的上升也进一步推动了对先进心血管设备的需求，因为这些疾病通常需要结合血管移植的手术方案来确保有效的治疗效果。

慢性肾臟病增加

慢性肾臟病（CKD）通常会发展为末期肾功能衰竭（ESRD），是血管移植市场的主要驱动力。 ESRD患者通常需要血液透析机，而血液透析则依赖可靠的血管网路基地台，例如动静脉瘻管（AVF）和动静脉移植物（AVG）。血管移植物在创建和维护这些网路基地台发挥关键作用，确保透析期间血液的有效过滤。随着全球慢性肾臟病（CKD）的增多，血液透析机的需求也在不断增长，从而推动了市场的扩张。

地理视角

美国作为主要市场

预计美国将成为预测期内规模最大、成长最快的血管移植市场。人口老化是推动这一增长的动力，这增加了动脉粥状硬化、冠状动脉疾病、周边动脉疾病和动脉瘤等血管疾病的风险。这些疾病通常需要外科手术干预，例如搭桥手术或动脉瘤修復，而这些手术依赖血管移植来恢復血流。这些疾病的盛行率不断上升，加上先进的医疗基础设施和对创新医疗解决方案的关注，使美国成为血管移植应用的主要市场。

受慢性肾臟病和心血管疾病（尤其是心臟病）发病率上升的推动，全球血管移植市场预计将强劲成长。透析和冠状动脉绕道手术（CABG）等外科手术的需求不断增长，凸显了血管移植在现代医疗保健中的关键作用。市场扩张由美国主导，美国人口老化，血管疾病发生率高，导致需求持续成长。随着医疗保健系统应对这些日益严峻的挑战，血管移植在改善患者预后和支持关键医疗程序方面仍将发挥重要作用。

本报告的主要优点

  • 深刻分析：获得涵盖主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场。
  • 竞争格局：了解主要企业采用的策略策略，并了解正确策略的市场渗透潜力。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力进行策略决策并在动态环境中开闢新的业务流和收益。
  • 受众范围广：对于新兴企业、研究机构、顾问、中小企业和大型企业来说都是有益且具成本效益的。

它有什么用途？

产业和市场考量、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范与影响、新产品开发、竞争影响

调查范围

  • 2020 年至 2024 年的历史数据和 2025 年至 2030 年的预测数据
  • 成长机会、挑战、供应链前景、法律规范与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 收益成长和预测细分市场和区域分析（包括国家）
  • 公司概况（尤其是趋势）、财务资讯和关键发展

目录

第一章 引言

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表

第二章调查方法

  • 调查数据
  • 先决条件

第三章执行摘要

  • 调查重点

第四章 市场动态

  • 市场驱动因素
  • 市场限制
  • 波特五力分析
  • 产业价值链分析

5. 全球血管移植市场（依来源）

  • 介绍
  • 合成
  • 半合成
  • 自然的

6. 全球血管假体市场（按适应症）

  • 介绍
  • 心血管系统
  • 肾臟疾病
  • 动脉瘤
  • 其他的

7. 全球血管移植市场（依最终用户）

  • 介绍
  • 医院和诊所
  • 门诊手术中心

8. 全球血管移植市场（按地区）

  • 介绍
  • 北美洲
    • 按来源
    • 按指示
    • 按最终用户
    • 按国家
      • 美国
      • 加拿大
      • 墨西哥
  • 南美洲
    • 按来源
    • 按指示
    • 按最终用户
    • 按国家
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 按来源
    • 按指示
    • 按最终用户
    • 按国家
      • 英国
      • 法国
      • 德国
      • 义大利
      • 其他的
  • 中东和非洲
    • 按来源
    • 按指示
    • 按最终用户
    • 按国家
      • 沙乌地阿拉伯
      • 以色列
      • 其他的
  • 亚太地区
    • 按来源
    • 按指示
    • 按最终用户
    • 按国家
      • 日本
      • 中国
      • 印度
      • 澳洲
      • 韩国
      • 泰国
      • 台湾
      • 印尼
      • 其他的

第九章：竞争格局及分析

  • 主要企业和策略分析
  • 新兴企业和市场盈利
  • 市场占有率分析
  • 供应商竞争力矩阵

第十章：公司简介

  • Getinge Group
  • WL Gore & Associates
  • B. Braun Melsungen AG
  • LeMaitre Vascular Inc.
  • Abbott Laboratories
  • Cook Medical
  • Terumo Medical Corporation
  • Cryolife
  • Medtronic PLC
  • Endologix Inc.
简介目录
Product Code: KSI061611564

The vascular graft market is expected to grow from USD 1.579 billion in 2025 to USD 2.038 billion in 2030, at a CAGR of 5.23%.

The global vascular graft market is experiencing significant growth, primarily driven by the rising prevalence of chronic kidney disease (CKD) and the increasing incidence of cardiovascular conditions, such as heart strokes. These health challenges necessitate advanced surgical interventions, including dialysis and coronary artery bypass grafting (CABG), which rely heavily on vascular grafts to restore or maintain critical blood flow. As the global burden of these diseases grows, the demand for reliable and effective vascular grafts continues to expand, positioning the market for sustained growth.

Key Growth Drivers

Rising Incidence of Heart Strokes

The increasing prevalence of heart disease and strokes is a major factor propelling the vascular graft market. Conditions such as coronary artery disease and microvascular flap-based reconstructions require procedures like CABG, which is among the most common cardiac surgeries globally. The growing need for these interventions drives demand for vascular grafts, which are essential for bypassing blocked arteries and restoring blood flow. The rising incidence of strokes further amplifies the need for advanced cardiovascular devices, as these conditions often necessitate surgical solutions that incorporate vascular grafts to ensure effective treatment outcomes.

Growing Prevalence of Chronic Kidney Disease

Chronic kidney disease, often progressing to end-stage renal disease (ESRD), is a significant driver of the vascular graft market. ESRD patients frequently require hemodialysis, which depends on reliable vascular access points such as arteriovenous fistulas (AVFs) or arteriovenous grafts (AVGs). Vascular grafts play a critical role in creating and maintaining these access points, enabling efficient blood filtration during dialysis. As the global incidence of CKD rises, the demand for vascular grafts to support hemodialysis continues to grow, further fueling market expansion.

Geographical Outlook

United States as a Leading Market

The United States is anticipated to be the largest and fastest-growing market for vascular grafts during the forecast period. This growth is driven by an aging population, which faces an elevated risk of vascular diseases such as atherosclerosis, coronary artery disease, peripheral artery disease, and aneurysms. These conditions often require surgical interventions, including bypass procedures and aneurysm repairs, which rely on vascular grafts to restore blood flow. The increasing prevalence of these health issues, combined with advanced healthcare infrastructure and a focus on innovative medical solutions, positions the U.S. as a key market for vascular graft adoption.

The global vascular graft market is poised for robust growth, driven by the rising prevalence of chronic kidney disease and cardiovascular conditions, particularly heart strokes. The increasing demand for dialysis and surgical interventions like CABG underscores the critical role of vascular grafts in modern healthcare. With the United States leading market expansion due to its aging population and high incidence of vascular diseases, the vascular graft market is expected to see sustained demand. As healthcare systems address these growing challenges, vascular grafts will remain essential in improving patient outcomes and supporting critical medical procedures.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2020 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Source

  • Synthetic
  • Semi-Synthetic
  • Natural

By Indication

  • Cardiovascular
  • Renal Disease
  • Aneurysms
  • Others

By End-User

  • Hospital & Clinics
  • Ambulatory Surgical Centers

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Taiwan
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Assumptions

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Force Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. GLOBAL VASCULAR GRAFT MARKET ANALYSIS, BY SOURCE

  • 5.1. Introduction
  • 5.2. Synthetic
  • 5.3. Semi-Synthetic
  • 5.4. Natural

6. GLOBAL VASCULAR GRAFT MARKET ANALYSIS, BY INDICATION

  • 6.1. Introduction
  • 6.2. Cardiovascular
  • 6.3. Renal Disease
  • 6.4. Aneurysms
  • 6.5. Others

7. GLOBAL VASCULAR GRAFT MARKET ANALYSIS, BY END-USER

  • 7.1. Introduction
  • 7.2. Hospital & Clinics
  • 7.3. Ambulatory Surgical Centers

8. GLOBAL VASCULAR GRAFT MARKET ANALYSIS, BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Source
    • 8.2.2. By Indication
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. United States
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Source
    • 8.3.2. By Indication
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Source
    • 8.4.2. By Indication
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. UK
      • 8.4.4.2. France
      • 8.4.4.3. Germany
      • 8.4.4.4. Italy
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Source
    • 8.5.2. By Indication
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. Israel
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Source
    • 8.6.2. By Indication
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. Japan
      • 8.6.4.2. China
      • 8.6.4.3. India
      • 8.6.4.4. Australia
      • 8.6.4.5. South Korea
      • 8.6.4.6. Thailand
      • 8.6.4.7. Taiwan
      • 8.6.4.8. Indonesia
      • 8.6.4.9. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Emerging Players and Market Lucrativeness
  • 9.3. Market Share Analysis
  • 9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

  • 10.1. Getinge Group
  • 10.2. W.L. Gore & Associates
  • 10.3. B. Braun Melsungen AG
  • 10.4. LeMaitre Vascular Inc.
  • 10.5. Abbott Laboratories
  • 10.6. Cook Medical
  • 10.7. Terumo Medical Corporation
  • 10.8. Cryolife
  • 10.9. Medtronic PLC
  • 10.10. Endologix Inc.